Rachel Lane

Investor type:

Social media:

Available after registration.

Past investments

  • Black Diamond Therapeutics
  • Kyras Therapeutics
  • CRISPR Therapeutics
  • Aligos Therapeutics
  • Aprea
  • CODA Biotherapeutics
  • Therachon
  • Inception IBD
  • Monteris Medical
  • Zyga Technology
  • Inari Medical
  • Century Therapeutics
  • Ceterix Orthopaedics
  • Audentes Therapeutics
  • Gotham Therapeutics
  • GenSight Biologics
  • Matterhorn Biosciences
  • Ventus Therapeutics
  • Benvenue Medical
  • Pandion Therapeutics
  • T-knife
  • Vividion Therapeutics
  • NeuWave Medical
  • PIQUR Therapeutics
  • Tarveda Therapeutics
  • VectivBio
  • Akero Therapeutics
  • Crinetics Pharmaceuticals
  • Graphite Bio
  • Jecure Therapeutics
  • RayzeBio
  • BlueRock Therapeutics
  • Sebacia
  • Repare Therapeutics
  • Enterprise Therapeutics
  • Kinestral Technologies
  • Intuity Medical
  • Metavention
  • Tempest Therapeutics
  • Bright Peak Therapeutics
  • Veran Medical Technologies
  • Respicardia
  • Nouscom
  • Nuvaira
  • Quentis Therapeutics
  • Passage Bio
  • Turnstone Biologics
  • Oyster Point Pharmaceuticals
  • Chinook Therapeutics
  • Monte Rosa Therapeutics
  • Pipeline Therapeutics
  • Twelve
  • Venatorx Pharmaceuticals
  • Gritstone Oncology
  • Jnana
  • Ebb Therapeutics
  • Lava Therapeutics
  • ROX Medical
  • AcuFocus
  • Anokion
  • Ivantis
  • Laguna Pharmaceuticals